Gilotrif is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Afatinib.
| Product ID | 0597-0137_256c019d-6658-43f0-8ec5-2dee75f0e92d | 
| NDC | 0597-0137 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Gilotrif | 
| Generic Name | Afatinib | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2013-07-12 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA201292 | 
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. | 
| Substance Name | AFATINIB | 
| Active Ingredient Strength | 30 mg/1 | 
| Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2013-08-09 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA201292 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2013-08-09 | 
| Marketing Category | NDA | 
| Application Number | NDA201292 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2018-10-01 | 
| Ingredient | Strength | 
|---|---|
| AFATINIB | 30 mg/1 | 
| SPL SET ID: | fd638e5e-8032-e7ca-0179-95e96ab5d387 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0597-0137 | Gilotrif | afatinib | 
| 0597-0138 | Gilotrif | afatinib | 
| 0597-0141 | Gilotrif | afatinib | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() GILOTRIF  86011486  4470944 Live/Registered  | 
        Boehringer Ingelheim International GmbH  2013-07-16  |